Finance

Lists
Why is 688136 down 3,86%?
Dive Deeper
688136:SHA
Kexing Biopharm Co Ltd
20,40 CNY
-3,86%
(-0,82) 1D
15 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688136...
Open
20,95 CNY
High
21,75 CNY
Low
20,29 CNY
Mkt. cap
4,43 მლრდ.
Avg. vol.
7,94 მლნ.
Volume
6,34 მლნ.
Dividend
1,23%
Quarterly dividend
0,06 CNY
Ex-dividend date
15 ივნ. 2026
P/E ratio
19,01
52-wk high
41,50 CNY
52-wk low
17,00 CNY
EPS
1,07 CNY
No. of employees
1 ათ.
Open
20,95 CNY
High
21,75 CNY
Low
20,29 CNY
Mkt. cap
4,43 მლრდ.
Avg. vol.
7,94 მლნ.
Volume
6,34 მლნ.
Dividend
1,23%
Quarterly dividend
0,06 CNY
Ex-dividend date
15 ივნ. 2026
P/E ratio
19,01
52-wk high
41,50 CNY
52-wk low
17,00 CNY
EPS
1,07 CNY
No. of employees
1 ათ.
News stories
From web sources and news partners
About Kexing Biopharm Co Ltd
CEO-
Employees1,11 ათ.
Founded22 აგვ. 1997
Headquarters-
Sector-
Websitekexing.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
447,17 მლნ.
386,39 მლნ.
280,53 მლნ.
326,60 მლნ.
Cost of goods sold
162,17 მლნ.
145,91 მლნ.
116,00 მლნ.
164,22 მლნ.
Cost of revenue
162,17 მლნ.
145,91 მლნ.
116,00 მლნ.
164,22 მლნ.
Research and development expenses
50,96 მლნ.
66,93 მლნ.
34,07 მლნ.
67,52 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,99 მლნ.
181,65 მლნ.
130,45 მლნ.
159,64 მლნ.
Operating expense
247,60 მლნ.
247,70 მლნ.
168,33 მლნ.
228,90 მლნ.
Total operating expenses
409,77 მლნ.
393,61 მლნ.
284,32 მლნ.
393,11 მლნ.
Operating income
37,41 მლნ.
-7,22 მლნ.
-3,80 მლნ.
-66,51 მლნ.
Other non operating income
4,38 მლნ.
-3,77 მლნ.
-7,85 მლნ.
7,38 მლნ.
EBT including unusual items
31,21 მლნ.
50,36 მლნ.
-25,83 მლნ.
172,90 მლნ.
EBT excluding unusual items
28,21 მლნ.
-15,50 მლნ.
-19,05 მლნ.
-80,87 მლნ.
Income tax expense
1,07 მლნ.
6,72 მლნ.
-7,28 მლნ.
21,86 მლნ.
Effective tax rate
3,43%
13,34%
28,18%
12,65%
Other operating expenses
3,60 მლნ.
3,58 მლნ.
1,19 მლნ.
3,46 მლნ.
Net income
30,92 მლნ.
44,30 მლნ.
-17,94 მლნ.
151,88 მლნ.
Net profit margin
6,91%
11,47%
-6,39%
46,50%
Earnings per share
-
-
-
-
Interest and investment income
4,79 მლნ.
3,35 მლნ.
3,04 მლნ.
956,57 ათ.
Interest expense
-10,40 მლნ.
-11,62 მლნ.
-10,44 მლნ.
-10,68 მლნ.
Net interest expenses
-5,61 მლნ.
-8,27 მლნ.
-7,40 მლნ.
-9,73 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
58,93 მლნ.
16,78 მლნ.
20,20 მლნ.
-41,95 მლნ.
Gain or loss from assets sale
-114,72 ათ.
-954,82 ათ.
-
-22,73 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები